Idexx Laboratories (IDXX) EBITDA (2016 - 2025)
Historic EBITDA for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $354.8 million.
- Idexx Laboratories' EBITDA rose 1676.71% to $354.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1746.11%. This contributed to the annual value of $1.1 billion for FY2024, which is 284.46% up from last year.
- Idexx Laboratories' EBITDA amounted to $354.8 million in Q3 2025, which was up 1676.71% from $373.0 million recorded in Q2 2025.
- Over the past 5 years, Idexx Laboratories' EBITDA peaked at $373.0 million during Q2 2025, and registered a low of $179.1 million during Q2 2022.
- Over the past 5 years, Idexx Laboratories' median EBITDA value was $261.7 million (recorded in 2024), while the average stood at $268.5 million.
- Per our database at Business Quant, Idexx Laboratories' EBITDA soared by 7157.25% in 2021 and then plummeted by 3093.0% in 2022.
- Over the past 5 years, Idexx Laboratories' EBITDA (Quarter) stood at $199.2 million in 2021, then rose by 13.72% to $226.5 million in 2022, then grew by 8.29% to $245.3 million in 2023, then increased by 6.68% to $261.7 million in 2024, then surged by 35.6% to $354.8 million in 2025.
- Its last three reported values are $354.8 million in Q3 2025, $373.0 million for Q2 2025, and $316.5 million during Q1 2025.